Peptide record

TPDB20408

Antibacterial Antiviral Toxicity standard
29 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20408
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia AI4AVP
standard
No
A 29-aa standard-residue multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia and AI4AVP, with an available 3D structural model.
Sequence
GLPVCGETCVGGTCNTPGCTCSKPVCTRN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C112H189N35O40S6
ADQHIMFWY
C
2858.30
7.63
2
1
4
+1
0.94
0.048
43.45
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
375
0.13
14
Residue Composition
number
0
A
1
R
2
N
0
D
6
C
1
E
0
Q
5
G
0
H
0
I
1
L
1
K
0
M
0
F
3
P
1
S
5
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 1 N: 2 D: 0 C: 6 E: 1 Q: 0 G: 5 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 3 S: 1 T: 5 W: 0 Y: 0 V: 3
Chemical Descriptors
29 reviewed residue count
C112H189N35O40S6 sequence-only estimate (linear, free termini)
2858.30 sequence-only estimate (linear, free termini)
7.63 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.94 sequence-only estimate (linear, free termini)
0.048 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

2% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
2% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. | J Biol Chem | 2011